Health Care · Pharmaceutical Preparations · Nasdaq · CIK 1580149 · FYE Jun 30 · Prices AT CLOSE 2026-07-29 (USD) — end-of-day, never a live or intraday quote
Last $1.26Day −5.26%Mkt cap $10M1Y −81.9%Off 52W high −82.4%Vol (1Y) 100.6%
Daily closing price, split-adjusted to the current basis; 3y shown of 2,434 bars on file. Sampled to 240 points — every point is a real close, none averaged. Price return, not total return (dividends excluded). Source marketstack.
| Short interest8.7% of sh out |
| Days to cover2.6d |
| 13F net flow (QoQ)+1.73% |
| Top-10 13F concentration92.6% |
| Next report (est.)2026-08-09 |
Short interest is FINRA semi-monthly, settlement 2026-07-15. 13F figures are quarterly filings, period 2026-Q1 — a lower bound on true ownership.
| Earnings (TTM)-$19.9M |
| ROE−101.6% |
Screener basis: ratios from the latest reported fiscal year; Sales/Earnings are trailing twelve months in the reporting currency (USD). The P/E is a trailing FULL-YEAR P/E, not TTM. Missing lines are absent from the filings, never imputed.
| YTD+8.6% |
| 1Y−81.9% |
| 3Y−99.7% |
| 5Y−99.9% |
| 10Y−94.5% |
| Since incept. (ann.)−22.8% |
Price return through 2026-07-29 · series begins 2014-05-05. Only the windows this history actually covers are shown.
| Ann. volatility (1Y)100.6% |
| Ann. volatility (3Y)137.2% |
| Sharpe (1Y)−1.19 |
| Sharpe (3Y)−0.75 |
| Max drawdown (1Y)−85.1% |
| Max drawdown (3Y)−99.8% |
| Beta (3Y vs SPY)−0.83 |
Daily simple returns, annualized; drawdown is peak-to-trough within the window. Beta is the OLS slope of monthly returns on SPY's over three years. Each figure is labeled by the window it was measured over — they are not comparable across windows.
| Manager | Shares | Value | % sh out | QoQ |
|---|---|---|---|---|
| Diametric Capital, LP | 370,000 | $518,000 | 4.91% | +0.0% |
| PRELUDE CAPITAL MANAGEMENT, LLC | 92,063 | $128,888 | 1.22% | +0.0% |
| GEODE CAPITAL MANAGEMENT, LLC | 84,203 | $117,884 | 1.12% | +52.0% |
| VANGUARD CAPITAL MANAGEMENT LLC | 84,067 | $117,694 | 1.11% | new |
| MORGAN STANLEY | 75,221 | $105,309 | 1.00% | +24.9% |
| PHILADELPHIA TRUST CO | 75,010 | $105,000 | 0.99% | +0.0% |
| RENAISSANCE TECHNOLOGIES LLC | 67,918 | $95,085 | 0.90% | +142.4% |
| CITADEL ADVISORS LLC | 45,292 | $63,409 | 0.60% | +149.5% |
Reported 13F long positions as filed for 2026-Q1 (change vs 2025-Q4). 13F covers US-listed long equity only — the sum is a LOWER BOUND on institutional ownership, never a total.
| Period end | Reported | EPS | EPS YoY | Revenue | Rev YoY |
|---|---|---|---|---|---|
| 2026-03-31 | 2026-05-11 | −$0.70 | — | — | — |
| 2025-12-31 | 2026-02-06 | −$0.77 | — | — | — |
| 2025-09-30 | 2025-11-10 | −$0.98 | — | — | — |
| 2025-03-31 | 2025-05-12 | — | — | — | — |
EPS and revenue as reported in this filer's own XBRL — our extraction of the filings, not a vendor consensus feed, and never a beat/miss claim (we carry no estimates). YoY compares the same fiscal quarter a year earlier. Next report 2026-08-09 is ESTIMATED from filing cadence (median gap 90d) — not company-confirmed.
